244 related articles for article (PubMed ID: 3197614)
1. [Salivary 17-hydroxyprogesterone concentration in monitoring of the treatment of congenital adrenal hyperplasia].
Arisaka O; Shimura N; Nakayama Y; Arisaka M; Yabuta K
Dtsch Med Wochenschr; 1988 Dec; 113(49):1913-5. PubMed ID: 3197614
[TBL] [Abstract][Full Text] [Related]
2. [Radioimmunoassay of salivary l7 alpha-hydroxyprogesterone. Values obtained in healthy subjects and in patients treated for congenital hyperplasia of the adrenal glands].
Guechot J; Fiet J; Gourmelen M; Pham-Huu-Trung MT; Raux-Eurin MC; Brerault JL; Gueux B; Villette JM
Ann Biol Clin (Paris); 1985; 43(4):333-7. PubMed ID: 4091295
[TBL] [Abstract][Full Text] [Related]
3. Correlation between androstenedione and 17-hydroxyprogesterone levels in the saliva and plasma of patients with congenital adrenal hyperplasia.
Juniarto AZ; Goossens K; Setyawati BA; Drop SL; de Jong FH; Faradz SM
Singapore Med J; 2011 Nov; 52(11):810-3. PubMed ID: 22173250
[TBL] [Abstract][Full Text] [Related]
4. Monitoring congenital adrenal hyperplasia using blood spot 17-hydroxyprogesterone assay.
Santos CM; Abad LR; Cua SC; Domingo CF
Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():174-8. PubMed ID: 15906729
[TBL] [Abstract][Full Text] [Related]
5. Enzyme immunoassay of 17-hydroxyprogesterone in plasma, microfilter paper blood and saliva of newborns, children and patients with congenital adrenal hyperplasia.
Hubl W; Fehér T; Rohde W; Dörner G; Taubert H; Freymann E
Endokrinologie; 1982 Jun; 79(2):165-72. PubMed ID: 6751805
[TBL] [Abstract][Full Text] [Related]
6. Morning salivary 17-hydroxyprogesterone is a useful screening test for nonclassical 21-hydroxylase deficiency.
Zerah M; Pang SY; New MI
J Clin Endocrinol Metab; 1987 Aug; 65(2):227-32. PubMed ID: 3496350
[TBL] [Abstract][Full Text] [Related]
7. [Determination of 17-hydroxyprogesterone levels in the treatment of children with the adrenogenital syndrome].
Vavrinec J; Dvorák P; Zizkovský V; Kopecký A; Pospísilová D; Starý J
Cesk Pediatr; 1983 Sep; 38(9):533-6. PubMed ID: 6315246
[No Abstract] [Full Text] [Related]
8. [Evaluation of salivary 17-hydroxyprogesterone and its clinical usefulness in the study of hirsutism and the partial deficiency of 21-hydroxylase].
Bonnín MR; Machuca I; Villabona C; González A; Soler J; Navarro MA
Med Clin (Barc); 1994 Feb; 102(5):169-71. PubMed ID: 8127165
[TBL] [Abstract][Full Text] [Related]
9. Detection of late-onset adrenal hyperplasia in girls with peripubertal virilization.
Sólyom J; Gács G; Keszei K; Láng K; Orley J; Petheö I; Ságodi L
Acta Endocrinol (Copenh); 1987 Jul; 115(3):413-8. PubMed ID: 3039770
[TBL] [Abstract][Full Text] [Related]
10. Salivary and plasma androstenedione and 17-hydroxyprogesterone levels in congenital adrenal hyperplasia.
Otten BJ; Wellen JJ; Rijken JC; Stoelinga GB; Benraad TJ
J Clin Endocrinol Metab; 1983 Dec; 57(6):1150-4. PubMed ID: 6605355
[TBL] [Abstract][Full Text] [Related]
11. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia.
Fiet J; Gueux B; Gourmelen M; Kuttenn F; Vexiau P; Couillin P; Pham-Huu-Trung MT; Villette JM; Raux-Demay MC; Galons H
J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244
[TBL] [Abstract][Full Text] [Related]
12. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
Theintz GE; Sizonenko PC
Arch Fr Pediatr; 1985 Mar; 42(3):211-7. PubMed ID: 4004483
[TBL] [Abstract][Full Text] [Related]
13. Monitoring treatment in congenital adrenal hyperplasia. Use of serial measurements of 17-OH-progesterone in plasma, capillary blood, and saliva.
Hughes IA; Dyas J; Robinson J; Walker RF; Fahmy DR
Ann N Y Acad Sci; 1985; 458():193-202. PubMed ID: 3879122
[No Abstract] [Full Text] [Related]
14. Screening for congenital adrenal hyperplasia: the Delfia Screening Test overestimates serum 17-hydroxyprogesterone in preterm infants.
al Saedi S; Dean H; Dent W; Stockl E; Cronin C
Pediatrics; 1996 Jan; 97(1):100-2. PubMed ID: 8545200
[TBL] [Abstract][Full Text] [Related]
15. Salivary 17 alpha-hydroxyprogesterone in congenital adrenal hyperplasia.
Walker RF; Hughes IA; Riad-Fahmy D
Clin Endocrinol (Oxf); 1979 Dec; 11(6):631-7. PubMed ID: 535169
[No Abstract] [Full Text] [Related]
16. [Andrenogenital syndrome (author's transl)].
Nieschlag E; Wenner H; Breu H; Wickings EJ; Schellong G
Dtsch Med Wochenschr; 1980 Apr; 105(17):600-3. PubMed ID: 7371512
[TBL] [Abstract][Full Text] [Related]
17. Studies on the diurnal variations of 17-hydroxyprogesterone in saliva by enzyme immunoassay in patients with congenital adrenal hyperplasia.
Hoepffner W; Hubl W
Exp Clin Endocrinol; 1986 Jul; 87(2):189-94. PubMed ID: 3530788
[TBL] [Abstract][Full Text] [Related]
18. [Neonatal levels of 17-hydroxyprogesterone--early diagnosis of adrenogenital syndrome].
Sulcová J; Tichá H; Wiererová O
Cesk Pediatr; 1989 Dec; 44(12):716-8. PubMed ID: 2636556
[TBL] [Abstract][Full Text] [Related]
19. [Methodical approaches to the determination of steroid hormone levels in different biological fluids in children with congenital dysfunction of the adrenal cortex].
Fofanova OV; Pankova SS; Kolesnikova GS
Pediatriia; 1989; (11):72-5. PubMed ID: 2608377
[TBL] [Abstract][Full Text] [Related]
20. [Use of steroid indicators in monitoring the treatment of congenital adrenal hyperplasia].
Sulcová J; Lisá L; Dvorák P; Hampl R; Stárka L
Cesk Pediatr; 1990 Jun; 45(6):353-6. PubMed ID: 2289256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
